LPA - lipoprotein(a) Gene
Also Known as Lp(a); Apo(a)
Species: Macaca mulatta
Gene Type: protein coding
Gene ID: 709528
LPA Products (1)
| mRNA | Protein | Name |
|---|---|---|
| XM_028847001.1 | XP_028702834.1 | LOW QUALITY PROTEIN: apolipoprotein(a) |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
apolipoprotein(a) LOW QUALITY PROTEIN: apolipoprotein(a) |
|
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(4)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-10341 | Fasudil Hydrochloride | 99.97% | Yes | |
| HY-10341A | Fasudil | 99.98% | Yes | |
| HY-10341C | Fasudil dihydrochloride | 99.98% | Yes | |
| HY-10341B | Fasudil hydrochloride semihydrate | / | Unkown |
Clinical Phase
Bioactive Molecules
(4)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-153492A | Olpasiran sodium | Inhibitor | 98.82% | Phase 3 |
| HY-100619 | BMS-986020 | Antagonist | 99.91% | Phase 2 |
| HY-152857 | Muvalaplin | Inhibitor | 99.96% | Phase 2 |
| HY-100619A | BMS-986020 sodium | Inhibitor | 99.88% | Phase 2 |
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P991310 | Lpathomab | Inhibitor | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(107)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-107614 | 1-Oleoyl lysophosphatidic acid sodium | Inducer | 99.96% | Unkown |
| HY-137862 | 1-Oleoyl lysophosphatidic acid | Activator | 99.96% | Unkown |
| HY-139853 | BMS-986278 | Antagonist | 99.95% | Yes |
| HY-13285 | Ki16425 | 99.14% | Unkown | |
| HY-132222 | SET2 | Antagonist | 99.78% | Unkown |
| HY-16040 | AM095 free acid | Inhibitor | 99.02% | Unkown |
| HY-15277 | AM966 | Antagonist | 99.86% | Unkown |
| HY-16039 | AM095 | Antagonist | 99.72% | Unkown |
| HY-107616 | H2L5186303 | 98.50% | Unkown | |
| HY-114379 | AS2717638 | Antagonist | 99.85% | Unkown |
| HY-117779 | DBIBB | 98.07% | Unkown | |
| HY-15706 | H2L 5765834 | Antagonist | 98.66% | Unkown |
| HY-145344 | ONO-8430506 | Inhibitor | 99.90% | Unkown |
| HY-150204 | ONO-0740556 | Agonist | 99.78% | Unkown |
| HY-107501 | (Rac)-1-Oleoyl lysophosphatidic acid sodium | 98.0% | Unkown | |
| HY-124772 | BI-2545 | Inhibitor | 98.85% | Unkown |
| HY-18075 | LPA2 antagonist 1 | Inhibitor | 98.63% | Unkown |
| HY-107615 | TC LPA5 4 | Antagonist | 99.69% | Unkown |
| HY-117444 | ONO-9780307 | Inhibitor | 99.94% | Unkown |
| HY-120967 | (2S)-OMPT triethylamine, in ethanol:chloroform (1:1), 98% | 99.0% | Unkown | |
| HY-W127502 | 1-Hexadecyl lysophosphatidic acid | 99.89% | Unkown | |
| HY-117959 | TAK-615 | Inhibitor | 98.07% | Unkown |
| HY-100676 | GRI977143 | 99.29% | Unkown | |
| HY-120797 | CRT0273750 | 98.81% | Unkown | |
| HY-158424 | LSN3353871 | Inhibitor | 99.62% | Unkown |
| HY-114380 | Radioprotectin-1 | Agonist | 99.49% | Unkown |
| HY-138453 | ACT-1016-0707 | Antagonist | 98.28% | Unkown |
| HY-100882 | ONO-7300243 | Antagonist | 98.11% | Unkown |
| HY-120478 | ASP6432 | Antagonist | 99.92% | Unkown |
| HY-175646 | AGPAT4-IN-1 | 99.04% | Unkown | |
| HY-18641 | Ki16198 | Antagonist | 98.17% | Unkown |
| HY-151391 | LPA5 antagonist 1 | 98.91% | Unkown | |
| HY-18076 | LPA1 receptor antagonist 1 | Antagonist | 99.13% | Unkown |
| HY-128127 | NAEPA | Agonist | ≥99.0% | Unkown |
| HY-145561 | Cudetaxestat | Inhibitor | 98.32% | Yes |
| HY-115450 | ONO-0300302 | Antagonist | 98.02% | Unkown |
| HY-116100A | HA155 | Inhibitor | 98.50% | Unkown |
| HY-103267 | S32826 disodium | Inhibitor | 98.85% | Unkown |
| HY-124072 | HL001 | 98.90% | Unkown | |
| HY-124535 | TGX-115 | Inhibitor | 99.31% | Unkown |
| HY-146956S | Oleoyl LPA-d5 | 98.0% | Unkown | |
| HY-157693 | C18:1 Cyclic LPA | 99% | Unkown | |
| HY-113973 | LPA2 antagonist 2 | Antagonist | 95.0% | Unkown |
| HY-120967A | (2S)-OMPT | / | Unkown | |
| HY-126233 | PAT-347 | Inhibitor | 98.63% | Unkown |
| HY-139061 | Palmitoyl 3-carbacyclic phosphatidic acid | Inhibitor | 99.9% | Unkown |
| HY-145486 | 1-Arachidonoyl-sn-glycerol 3-phosphate ammonium | / | Unkown | |
| HY-146945S | Arachidonoyl LPA-d5 | / | Unkown | |
| HY-146955S | Linoleoyl LPA-d5 | / | Unkown | |
| HY-151392 | LPA5 antagonist 2 | Antagonist | 99.62% | Unkown |
| HY-167862A | UCM-05194 ammonium | Agonist | / | Unkown |
| HY-167862 | UCM-05194 | 90.0% | Unkown | |
| HY-W923661 | 1-Octadecyl lysophosphatidic acid | Activator | 95% | Unkown |
| HY-184076 | Ibrilparant | / | Unkown | |
| HY-103267A | S32826 | Inhibitor | / | Unkown |
| HY-107614G | 1-Oleoyl lysophosphatidic acid sodium (GMP) | Activator | / | Unkown |
| HY-118539 | NSC12404 | Agonist | / | Unkown |
| HY-119013 | VPC32183 | / | Unkown | |
| HY-119601 | GRI918013 | Inhibitor | / | Unkown |
| HY-123522 | PAT-048 | Inhibitor | / | Unkown |
| HY-126230 | PAT-494 | / | Unkown | |
| HY-126230A | (Rac)-PAT-494 | / | Unkown | |
| HY-126233A | PAT-347 sodium | Inhibitor | / | Unkown |
| HY-126967AS | 1-Palmitoyl-sn-glycerol 3-phosphate-d9 | / | Unkown | |
| HY-129808 | VPC12249 | Antagonist | / | Unkown |
| HY-130011 | CCG-232964 | Inhibitor | / | Unkown |
| HY-137862A | (Rac)-1-Oleoyl lysophosphatidic acid | Control | / | Unkown |
| HY-148291 | BrP-LPA sodium | / | Unkown | |
| HY-157617 | 16:0 Cyclic LPA ammonium | / | Unkown | |
| HY-157669 | 1-Oleoyl-sn-glycero-2,3-cyclic-phosphate ammonium | / | Unkown | |
| HY-160616 | LPA5 antagonist 3 | Antagonist | / | Unkown |
| HY-160823 | 2ccPA sodium | Inhibitor | / | Unkown |
| HY-171464A | Lp(a)-IN-5 hydrochloride | Inhibitor | 99.70% | Unkown |
| HY-171465 | Lp(a)-IN-6 | / | Unkown | |
| HY-171806 | BMT-136088 | Ligand | / | Unkown |
| HY-171906A | 1-Arachidonoyl-2-hydroxy-sn-glycero-3-PA sodium | Inhibitor | / | Unkown |
| HY-173322 | Lp(a)-IN-8 | Inhibitor | / | Unkown |
| HY-173323 | Lp(a)-IN-7 | Inhibitor | / | Unkown |
| HY-173324 | LPA2 antagonist 5 | Antagonist | / | Unkown |
| HY-173325 | LPA2 antagonist 6 | Antagonist | / | Unkown |
| HY-173509 | ATX inhibitor 27 | Inhibitor | / | Unkown |
| HY-174267S | ATX-IN-2 | Inhibitor | / | Unkown |
| HY-175084 | 1-Hexadecyl lysophosphatidic acid sodium | Activator | / | Unkown |
| HY-178845 | Decyl phosphate | Modulator | / | Unkown |
| HY-179580 | EL244 | 99.55% | Unkown | |
| HY-181452 | 1-Arachidoyl-2-hydroxy-sn-glycero-3-PA sodium | / | Unkown | |
| HY-182787 | LPA1 receptor antagonist-7 | Antagonist | / | Unkown |
| HY-404647 | FK3453 | Inhibitor | / | Unkown |
| HY-N15794 | AzoLPA ammonium | Activator | / | Unkown |
| HY-N15931 | 18:1 1,3-Cyclic LPA ammonium | / | Unkown | |
| HY-N16000 | 12:0 Biotinyl LPA ammonium | / | Unkown | |
| HY-RS07745 | LPA Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W040175 | L-NASPA ammonium | Inhibitor | / | Unkown |
| HY-W040176 | N-PTyrosine PA ammonium | Modulator | / | Unkown |
| HY-W725737 | BrP-LPA | / | Unkown | |
| HY-W783254 | C18 LPA | / | Unkown | |
| HY-10341D | Fasudil mesylate | / | Unkown | |
| HY-139133 | L-NASPA | Inhibitor | / | Unkown |
| HY-160003 | PPARγ agonist 9 | Agonist | / | Unkown |
| HY-160173 | LPA receptor antagonist-1 | Antagonist | / | Unkown |
| HY-171464 | Lp(a)-IN-5 | Inhibitor | / | Unkown |
| HY-171906 | 1-Arachidonoyl-2-hydroxy-sn-glycero-3-PA | Inhibitor | / | Unkown |
| HY-172566 | 1-Myristyl-2-hydroxy-sn-glycero-3-PA | Activator | / | Unkown |
| HY-181456 | 1-Octadecyl-2-hydroxy-sn-glycero-3-phosphate sodium | / | Unkown | |
| HY-N16077 | C16 Cyclic LPA ammonium | / | Unkown | |
| HY-N16110 | 17:0 Cyclic LPA ammonium | / | Unkown | |
| HY-W725317 | C16 LPA ammonium | / | Unkown |